ArticleF1000Research2025
An Improved Deep Learning Algorithm for Breast Cancer Survival Prediction Based on Multi-Omics Data.
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gene driven analytical learning model for accurate breast cancer diagnosis.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is a leading cause of mortality among women worldwide. Accurate survival prediction can improve clinical decision-making and support personalized treatment planning. This study aims to develop an interpretable and effective deep learning model for breast cancer survival prediction using multi-omics data. Methods: This study proposes a novel deep learning model combining Bi-directional Long Short-Term Memory (BiLSTM) and Convolutional Neural Network (CNN) architectures, integrated with Minimum Redundancy Maximum Relevance (MRMR) feature selection. The model was evaluated on two large datasets: METABRIC (n=1980) and TCGA-BRCA (n=1080), using clinical, copy number alteration (CNA), and gene expression data. Performance was assessed through metrics such as AUC-ROC and accuracy. Results: The proposed model demonstrated superior performance compared to existing algorithms, achieving high AUC-ROC and accuracy values across all data modalities. The integration of BiLSTM and CNN architectures allowed the model to capture temporal and spatial patterns, improving prediction robustness. Notably, the model achieved an accuracy of 98% on the METABRIC dataset and 96% on the TCGA dataset. Conclusions: The combination of BiLSTM, CNN, and MRMR offers an interpretable and accurate framework for breast cancer survival prediction using multi-omics data. This approach provides actionable insights for clinicians and highlights its potential for broader applications in oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.